SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 28th, 2016 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • California
This Second Amended and Restated Employment Agreement (the “Agreement”) is entered into effective as of January 1, 2017 by and between Mateon Therapeutics, Inc. (f.k.a. OXiGENE, Inc.), a Delaware corporation (the “Company”), and Dr. David Chaplin, an individual (the “Executive”).
